Sibiricose A1
The sibiricosee A1, the sibiricose A5 and the tenuifoliside A have a better treatment function for tristimania caused by various reasons the sibiricose A5 and the tenuifoliside A have a certain protecting function for PC 12 cells damaged by glutamic acid and the sibiricosee A1, the sibiricose A5 and the tenuifoliside A all can shorten the tail-hanging resting time and the swim resting time of a mouse.
Inquire / Order:
manager@chemfaces.com
Technical Inquiries:
service@chemfaces.com
Tel:
+86-27-84237783
Fax:
+86-27-84254680
Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to
24 months(2-8C).
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com
The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
Journal of Molecular Liquids2022, 364:120062.
PLoS One.2017, 12(3):e0173585
J Mol Recognit.2020, 33(2):e2819
Molecules.2023, 28(4):1785.
Exp Parasitol.2018, 194:67-78
TCI CO.2019, US20190151281A1
Biomed Pharmacother.2024, 181:117647.
Nutrients.2023, 15(12):2810.
Molecules.2019, 24(17):E3127
Biochem Pharmacol.2023, 211:115502.
Related and Featured Products
CN20081097491 on 30 May 2008
Application of sibiricose A1, sibiricose A5 and tenuifoliside A in preparing tristimania treating products.[Reference:
WebLink]
METHODS AND RESULTS:
The invention discloses a new medicinal application of Sibiricose A1, sibiricose A5 and tenuifoliside A, in particular to an application of Sibiricose A1, sibiricose A5 and tenuifoliside A in preparing tristimania treating products. The sibiricosee A1, the sibiricose A5 and the tenuifoliside A have a better treatment function for tristimania caused by various reasons the sibiricose A5 and the tenuifoliside A have a certain protecting function for PC 12 cells damaged by glutamic acid and the sibiricosee A1, the sibiricose A5 and the tenuifoliside A all can shorten the tail-hanging resting time and the swim resting time of a mouse. Compared with a mould group, a dose group has marked difference in statistics and dose dependence and shows a better anti-depression effect.
